There is evidence that nitric oxide, an endothelium-derived relaxing factor, may be produced by the macula densa, as well as by blood vessels, within the kidney. To examine the role of nitric oxide in macula densa control of glomerular hemodynamics directly, we performed in vitro microperfusions of both rabbit afferent arterioles (with the glomerulus intact) and adherent tubular segments consisting of portions of the thick ascending limb, macula densa, and early distal tubule. While keeping afferent arteriolar pressure constant at 60 mmHg, we examined the effect of Nw-nitro-L-arginine methyl ester (L-NAME), an inhibitor of nitric oxide synthesis, added to a macula densa perfusate. When the macula densa perfusate was changed from low to high NaCl, the diameter of the arterioles decreased from 163±1.0 to 14.0±1.1 ,m (n = 10; P < 0.001). Addition of i0-5 M L-NAME to the high NaCO solution further decreased the diameter to 11.9±1.1 gm (P < 0.001). In contrast, when macula densa perfusion was maintained with the low NaCl solution, addition of L-NAME had no effect. L-NAME-induced constriction was completely reversed by adding 10-3 M L-arginine (the precursor of nitric oxide) but not D-arginine (an inactive isomer) to the macula densa perfusate. We confirmed that perfusing the macula densa with L-NAME did not affect the vasodilator action of acetylcholine added to the lumen of the afferent arteriole, indicating that NO synthesis by the arteriole was not altered. Thus, our findings suggest that the macula densa may produce nitric oxide, which in turn modulates the afferent arteriolar constriction induced by high concentrations of NaCl at the macula densa. (J. Clin. Invest.
Introduction
In each nephron of the mammalian kidney, the tubule returns to the hilus ofthe parent glomerulus, forming thejuxtaglomerular apparatus that displays a unique arrangement ofglomerular afferent arteriole (Af-Art)' and efferent arteriole (Ef-Art), interstitial cells and macula densa (MD) (1) . Because of this intimate anatomical relationship, it has long been suggested that the MD may somehow sense changes in the composition of the tubular fluid and control the GFR (2) by a mechanism called tubuloglomerular feedback. It has been shown that tubuloglomerular feedback plays an important role in renal autoregulation, as well as homeostasis of fluid volume and electrolytes (3) (4) (5) (6) . Alteration of tubuloglomerular feedback has been reported in many physiological and pathological conditions, such as hypertension, high protein intake, uninephrectomy, hyperglycemia, and dehydration (7, 8) . Numerous in vivo single-nephron micropuncture studies have established that increased NaCl concentration and/or osmolality of the tubular fluid at the MD decreases single-nephron GFR. Most studies indicate that changes in Af-Art resistance play a major (and most likely a dominant) role in altering GFR (9) . Despite intensive investigation, however, the mechanism of MD-mediated glomerular hemodynamics remains incompletely understood.
Since the discovery of endothelium-derived relaxing factor (EDRF) by Furchgott and Zawadzki (10), it has been studied extensively in various organs including the kidney. An EDRF has been identified as nitric oxide (NO), which is synthesized enzymatically from the amino acid L-arginine ( 11) . Although studies have demonstrated that NO plays an important role in the control of renal function ( 12) , its site and mechanism of action are yet to be elucidated. We have previously shown that in isolated microperfused rabbit Af-Arts, inhibition ofNO synthesis not only decreases basal diameter but also augments the vasoconstrictor action ofangiotensin II ( 13) . This suggests that NO produced locally within the Af-Art is an important determinant of glomerular hemodynamics. On the other hand, NO may directly influence tubular transport independently of renal hemodynamics ( 14). Furthermore, a recent study suggests that type I NO synthase, which is a different isoform from the type III found in the endothelium, is abundant in the MD cells ( 15 ) .
In this study, we tested the hypothesis that the MD cells produce NO, which in turn modulates the Af-Art constriction induced by increased NaCl concentration at the MD. For this, we used a novel and recently established in vitro preparation in which both the isolated Af-Art and attached MD are microper-fused simultaneously (Fig. 1) . We have previously shown that increasing NaCl concentration of the MD perfusate causes constriction of the Af-Art, particularly in the distal segment ( 16, 17) . Our preparation has the advantage of allowing us to observe the Af-Art directly in the absence ofsystemic hemodynamic and hormonal influences while controlling both pressure in the Af-Art and the composition of the tubular fluid at the MD.
Methods
Isolation and microperfusion ofthe rabbit Af-Art with MD attached
We used a method similar to that described previously to isolate and microperfuse Af-Arts with MD attached ( 13, 16 
Experimental protocols
Response to Nw-nitro-L-arginine methyl ester (L-NAME) added to MD perfusate containing either high or low NaCl. In four experiments, the MD was perfused with a modified Krebs-Ringer bicarbonate buffer containing high NaCl from the equilibration period to the end of the experiment. The high NaCl solution had the following composition: 1 5 mM NaCl, 15 mM NaHCO3, 10 mM sodium acetate, 0.96 mM NaH2PO4, 0.24 mM Na2HPO4, 5 mM KCI, 1.2 mM MgSO4, 1 mM CaCI2, and 5.5 mM glucose (total osmolality, 280 mosmol/kg). After the 30-min equilibration period, two increasing concentrations of L-NAME (Sigma) (10-5 and l0-4 M) were added to the MD perfusate.
Luminal diameters of the Af-Arts were measured immediately before adding L-NAME and observed for 20 min at each dose. Because oftime constraints, we tested only two concentrations of L-NAME for each preparation, since our previous studies have shown that MD-mediated Af-Art responses are consistent over a 45-min period ( 16, 17) . Since we observed that Af-Art responses reached a maximum at l0-5 M (see the Results), we used lower concentrations( 10-6 and 10-5 M) of L-NAME in subsequent studies. In seven experiments, we examined the effect of L-NAME when the NaCl concentration at the MD was low. The MD was perfused with a low NaCl solution that was identical to the high NaCl solution, except that NaCl was removed without correcting osmolality (88 mosmol/kg). After the equilibration period, L-NAME was added to the MD perfusate for 20 min at each dose ( 10 -s and 10 -4 M). In another 10 experiments, we examined the influence of the high-NaCl MD perfusate on basal diameter, as well as changes induced by the addition of L-NAME. The MD was perfused with the low NaCl solution during the equilibration period, after which the perfusate was changed to the high NaCl solution for the remainder of the experiment. 5 min later, L-NAME was added to the MD perfusate and Af-Arts observed for 20 min at each dose.
Effect of L-or D-arginine on L-NAME-induced constriction. We examined whether Af-Art vasoconstriction induced by adding L-NAME to a high NaCl MD perfusate is specifically caused by inhibition of NO synthesis from L-arginine ( 11). While perfusing the MD with the high NaCl solution, we first added 10-5 M L-NAME, after which either L-arginine or its inactive isomer, D-arginine, at l0-3 M (Sigma) was added to the perfusate together with L-NAME.
Effect ofintraarteriolar acetylcholine during L-NAME perfusion of the MD. We conducted experiments to rule out the possibility that the observed changes in Af-Art diameter were secondary to inhibition of NO synthesis in the Af-Art rather than the MD cells. While perfusing the MD with 10-5 M L-NAME, we constricted the Af-Art to 60-70% of basal diameter by adding 10-' M norepinephrine to the bath, after which acetylcholine ( 10-6 and l0-5 M) was added only to the lumen of the Af-Arts (n = 6).
Statistics
Values were expressed as mean±SEM. A paired t test was used to examine whether the diameter at a given concentration was different from the control value. Analysis of covariance was used to examine whether the change in diameter at a given concentration was different between groups. For both analyses, P < 0.025 (0.05/2; Bonferroni adjustment) was considered significant.
Results
Response to L-NAME added to MD perfusate containing either high or low NaCl. Figure 2 shows an example ofthe response to I0 -I and 10-4 M L-NAME added to ,gm at 10-6 and I0 -M, respectively). When the MD perfusate was changed from low to high NaCi, basal diameter decreased from 16.3±1.0 to 14.0±1 .1 m (n = 10; P < 0.001 ). In contrast to L-NAME's lack of effect with the low NaCl perfusate, addition of L-NAME ( 10-6 and 10 -5 M) to the high NaCl solution further decreased the diameter to 12.8±1.0 (P < 0.01) and 1 1.9±1.1 Lm (P < 0.001 ), respectively. Fig. 3 depicts the percent change in Af-Art diameter induced by adding 10-6 and l0-5 M L-NAME to either the high or low NaCl perfusate. Only when the MD was perfused with the high NaCl solution, did L-NAME at 10-6 and I0O-M decrease arteriolar diameter by 8 .1±1.7% (P < 0.00 I ) and 15.6±2.8% (P < 0.00 I ), which in theory, would increase vascular resistance by 40 and 90%, respectively. Fig. 4 depicts individual values for changes in arteriolar diameter induced by adding 10-5 M L-NAME to the high NaCl MD perfusate. It is evident that the arteriolar response was both consistent and reproducible.
Effect ofL-orD-arginine on L-NAME-induced constriction.
L-NAME (10-5 M) added to the high NaCl MD perfusate decreased Af-Art diameter to 84.5±1.9% of control (P < 0.01; n = 5 ), while addition of I0O3 M L-arginine reversed the diameter to control levels (98.9±4.1% ). On the other hand, D-arginine had no effect on L-NAME-induced constriction: with L-NAME, the diameter decreased to 76.2±2.6% of control (P < 0.01; n = 4), and remained unchanged after addition of I0-M D-arginine (74.4±5.3%).
Effect ofintraarteriolar acetylcholine during L-NAME perfusion of the MD. While the MD was perfused with 10-5 M L-NAME, 10-7 M norepinephrine was added to the bath; it constricted the Af-Art to 62.0±5.5% of basal diameter (P < 0.0001; n = 8). When acetylcholine was added only to the lumen of the Af-Art at 10-6 and 10-5 M, the diameter increased to 101 ± 11.9 (P < 0.003 vs norepinephrine) and 110± 11.9% of baseline (P < 0.002), respectively. .,..?
synthase are more abundant in the cytoplasm of MD cells than in any other structure (including the vascular endothelium) within the kidney. Their study provides a morphological basis for the role of NO in the control ofglomerular hemodynamics and/or renin release by the MD. We now present direct evidence that the MD may indeed produce NO, which, in turn, modulates the vascular response of the Af-Art, a major vascular segment that controls glomerular hemodynamics. The present study demonstrates that adding L-NAME (an inhibitor of NO synthesis) only to the MD perfusate constricts the Af-Art. Constriction is seen with a high but not a low NaCl MD perfusate, suggesting that NO produced within the MD Figure 2 . Afferent arteriolar constriction induced by lo-5 and IO -M L-NAME (an inhibitor of nitric oxide synthesis) added to a macula densa perfusate with a high NaCi concentration. Note that Io-5 and IO-4 M L-NAME caused similar constriction of the afferent arteriole, which is strongest in the distal segment. cells and/or juxtaglomerular interstitium modulates the AfArt constriction induced by high concentrations ofNaCl at the MD. Since L-NAME-induced vasoconstriction is abolished by L-arginine (the precursor of NO), but not D-arginine (an inactive isomer ofL-arginine), the constriction observed with intratubular L-NAME seems to be specifically caused by inhibition of NO synthesis from L-arginine. Our results are consistent with a recent in vivo micropuncture study by Wilcox et al. ( 18, 19) , who reported that perfusing the loop of Henle with L-NAME lowered the stop-flow pressure, and that this decrease was abolished by adding L-arginine.
The MD perfusate issues into bath in our preparation. How- ever, it is unlikely that the L-NAME concentration in the bath reached high enough concentrations to affect the Af-Art, since the rate of MD perfusion was 10 nl/min, while the bath was 100 ul and was exchanged continuously at a rate of 1 ml/mmin. Nevertheless, we conducted experiments to rule out the possibility that the observed changes in Af-Art diameter were secondary to inhibition of NO synthesis in the Af-Art rather than in the MD cells. While perfusing the MD with 10-5 M L-NAME, we examined the vasodilator action of acetylcholine (which stimulates NO synthesis by the endothelium) added directly to the lumen ofAf-Arts, which had been preconstricted to 65% ofcontrol diameter with norepinephrine. Acetylcholine at both 10-6 and I0-5 M caused significant vasodilation, completely reversing the diameter to 101 and 1 10% of control values, respectively. The acetylcholine-induced dilation was similar to that observed in nontreated Af-Arts, suggesting that NO synthesis in the Af-Art was not significantly altered under our experimental conditions. Furthermore, when L-NAME was added to the lumen ofthe Af-Arts at doses of l0-I , 10-6, l0-1, tively (n = 11 ). Thus, even though the Af-Art endothelium was exposed to L-NAME directly, the maximum arteriolar response was not obtained until the concentration reached l0-4 M. On the other hand, when L-NAME was added to the MD perfusate, it induced a maximum response already at doses as low as 10-' M (Fig. 2) . The disparate dose-response curves suggest that the mechanism of Af-Art contraction induced by these two routes of L-NAME administration is different. The mechanism by which L-NAME induced Af-Art constriction with a high-but not a low-NaCI MD perfusate is not clear. It may be that in response to increased tubular transport, the MD produced not only a vasoconstrictor signal (as yet undefined) but also NO, which opposed each other's actions at the level of Af-Art. Alternatively, the MD may have continuously released NO independently of tubular transport; however, when the MD was perfused with the low NaCl solution, the vasodilator action of NO may have not been apparent because of already low basal Af-Art resistance, whereas with the high NaCl perfusate NO We have previously presented evidence that the Af-Art produces NO, which is important in the control of basal tone, as well as the vascular response to both angiotensin II and endothelin ( 13, 20) . The present study provides evidence that NO within the MD and/orjuxtaglomerular interstitium may function independently ofthat produced by the renal vasculature. It is conceivable that the activity of NO in these two compartments is differentially regulated under various physiological and pathological conditions. Interestingly, a recent preliminary report indicates that immunoreactivity of NO synthase in the MD was greatly reduced by dietary sodium restriction, suggesting that decreased activity of NO in the MD may contribute to augmented TGF response seen during sodium restriction ( 18) . In addition to glomerular hemodynamics, the MD controls renin release in response to changes in the composition of tubular fluid (6) . Therefore, it may be possible that NO produced in the MD versus Af-Art endothelium may have different effects on renin release.
In conclusion, we have demonstrated that perfusion of the MD with L-NAME causes constriction of the Af-Art, which seems to be caused by inhibition of NO synthesis (from L-arginine) in the MD and/orjuxtaglomerular interstitium but not in the Af-Art. L-NAME-induced constriction is seen only when the MD is perfused with high but not low NaCl, suggesting that MD cells may produce NO, which in turn modulates the AfArt constriction induced by increased NaCl concentration at the MD. Thus, our data provide direct evidence for the functional role of NO in the juxtaglomerular apparatus.
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